QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer Identification No.) |
|
|
|
|
|
||
|
||
|
||
(Address of principal executive offices)
|
(Zip Code)
|
Title of Each Class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
The |
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
|
☒
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
|
TABLE OF CONTENTS
|
|
PAGE
NO.
|
||
PART I
|
FINANCIAL INFORMATION
|
|
Item 1
|
5 |
|
5 |
||
6
|
||
7 |
||
9 |
||
10 |
||
12 | ||
Item 2
|
29 | |
Item 3
|
44 |
|
Item 4
|
46 |
|
PART II
|
OTHER INFORMATION
|
|
Item 1
|
46 |
|
Item 1A
|
46 |
|
Item 2
|
46 |
|
Item 3
|
46 |
|
Item 4
|
46 | |
Item 5
|
46 |
|
Item 6
|
46 |
|
48
|
• |
our future operating results and distribution projections;
|
• |
the ability of Chicago Atlantic BDC Advisers, LLC (“Adviser”) to attract and retain highly talented professionals;
|
• |
our business prospects and the prospects of our portfolio companies;
|
• |
the impact of interest and inflation rates on our business prospects and the prospects of our portfolio companies;
|
• |
the impact of the investments that we expect to make;
|
• |
the ability of our portfolio companies to achieve their objectives;
|
• |
our expected financings and investments and the timing of our investments in our initial portfolio;
|
• |
changes in regulation impacting the cannabis industry;
|
• |
the adequacy of our cash resources and working capital;
|
• |
the current and future effects of the COVID-19 pandemic on us and our portfolio companies;
|
• |
the timing of cash flows, if any, from the operations of our portfolio companies; and
|
• |
the ability to realize benefits anticipated by the Loan Portfolio Acquisition (as defined below). See “Note 12 – Subsequent Events” in the notes to the financial statements included with this quarterly report on Form 10-Q for
further information regarding the Loan Portfolio Acquisition.
|
• |
our limited operating history;
|
• |
changes or potential disruptions in our operations, the economy, financial markets or political environment;
|
• |
risks associated with possible disruption in our operations or the economy generally due to terrorism, natural disasters, the Russia-Ukraine war, or the Israel-Hamas war and the potential for volatility in energy prices and other
commodities and their impact on the industries in which we invest;
|
• |
the impact of information technology system failures, data security breaches, data privacy compliance, network disruptions, and cybersecurity attacks;
|
• |
future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to business development companies
(“BDCs”) or regulated investment companies (“RICs”); and
|
• |
other considerations that may be disclosed from time to time in our publicly disseminated documents and filings.
|
|
September 30, 2024 |
December 31, 2023
|
||||||
|
(unaudited)
|
|||||||
ASSETS
|
||||||||
Investments at fair value:
|
||||||||
Non-control/non-affiliate investments at fair value (amortized cost of $
|
$
|
|
$
|
|
||||
Cash and cash equivalents
|
|
|
||||||
Interest receivable
|
|
|
||||||
Deferred offering costs |
||||||||
Other receivable |
||||||||
Prepaid expenses
|
|
|
||||||
Other assets | ||||||||
Deferred financing costs |
||||||||
Paydown receivable
|
||||||||
Total assets
|
|
|
||||||
|
||||||||
LIABILITIES
|
||||||||
Transaction fees payable related to the Loan Portfolio Acquisition |
||||||||
Offering costs payable |
||||||||
Management fee payable
|
||||||||
Audit fees payable
|
||||||||
Capital gains incentive fees payable | ||||||||
Legal fees payable
|
||||||||
Administrator fees payable
|
||||||||
Due to affiliate |
||||||||
Unearned interest income
|
||||||||
Deferred financing costs payable
|
||||||||
Directors fees payable |
||||||||
Other payables |
||||||||
Valuation fees payable
|
||||||||
Professional fees payable |
||||||||
Income-based incentive fees payable
|
||||||||
Distributions payable |
||||||||
Excise tax payable |
||||||||
Total liabilities
|
|
|
||||||
|
||||||||
Commitments and contingencies (Note 6)
|
||||||||
|
||||||||
NET ASSETS
|
||||||||
Common Stock, $
|
|
|
||||||
Additional paid-in-capital
|
|
|
||||||
Distributable earnings (Accumulated losses)
|
(
|
)
|
|
|||||
Total net assets
|
$
|
|
$
|
|
||||
Total liabilities and net assets
|
$ | |||||||
NET ASSET VALUE PER SHARE
|
$
|
|
$
|
|
|
Three Months Ended
|
Nine Months Ended |
||||||||||||||
|
September 30, 2024
|
September 30, 2023
|
September 30, 2024 |
September 30, 2023 |
||||||||||||
INVESTMENT INCOME
|
||||||||||||||||
Non-control/non-affiliate investment income
|
||||||||||||||||
Interest income
|
$
|
|
$
|
|
$ | $ | ||||||||||
Fee income
|
|
|
||||||||||||||
Total investment income
|
|
|
||||||||||||||
|
||||||||||||||||
EXPENSES
|
||||||||||||||||
Transaction expenses related to the Loan Portfolio Acquisition
|
|
|
||||||||||||||
Management fee
|
||||||||||||||||
Income-based incentive fees
|
||||||||||||||||
Audit expense
|
||||||||||||||||
Administrator fees
|
|
|
||||||||||||||
Legal expenses
|
|
|
||||||||||||||
Insurance expense
|
||||||||||||||||
Other expenses
|
||||||||||||||||
Director expenses
|
|
|
||||||||||||||
Professional fees |
||||||||||||||||
Valuation fees
|
||||||||||||||||
Capital gains incentive fees
|
( |
) | ( |
) | ||||||||||||
Custodian fees
|
||||||||||||||||
Excise tax expense
|
||||||||||||||||
Total expenses
|
|
|
||||||||||||||
|
||||||||||||||||
NET INVESTMENT INCOME (LOSS)
|
|
|
||||||||||||||
|
||||||||||||||||
NET REALIZED GAIN (LOSS) FROM INVESTMENTS
|
||||||||||||||||
Non-controlled/non-affiliate investments
|
( |
) | ||||||||||||||
Net realized gain (loss) from investments
|
|
|
( |
) | ||||||||||||
NET CHANGE IN UNREALIZED APPRECIATION (DEPRECIATION) FROM INVESTMENTS
|
||||||||||||||||
Non-controlled/non-affiliate investments
|
(
|
)
|
(
|
)
|
||||||||||||
Net change in unrealized appreciation (depreciation) from investments
|
(
|
)
|
(
|
)
|
||||||||||||
Net realized and unrealized gains (losses) |
( |
) | ( |
) | ( |
) | ||||||||||
|
||||||||||||||||
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
|
||||||||||||||||
NET INVESTMENT INCOME (LOSS) PER SHARE — BASIC AND DILUTED
|
$
|
(1) |
$
|
|
$ | $ | ||||||||||
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE — BASIC AND DILUTED
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
WEIGHTED AVERAGE SHARES OUTSTANDING — BASIC AND DILUTED
|
|
|
(1) |
|
|
Common Stock
|
|||||||||||||||||||
Three Months Ended
September 30, 2024
|
Shares
|
Par Value
|
Additional
paid-in-capital |
Distributable Earnings/
(Accumulated Loss)
|
Total
net assets
|
|||||||||||||||
Balance, June 30, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
Net increase (decrease) in net assets resulting from operations
|
||||||||||||||||||||
Net investment income (loss)
|
-
|
|
|
|
|
|||||||||||||||
Net realized gain (loss) from investments
|
-
|
|
|
|
|
|||||||||||||||
Net change in unrealized appreciation (depreciation) from investments
|
-
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Total net increase (decrease) in net assets resulting from operations
|
-
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Distributions to stockholders from:
|
||||||||||||||||||||
Investment income-net
|
- | ( |
) | ( |
) | |||||||||||||||
Capital transactions
|
||||||||||||||||||||
Reinvestment of stockholder distributions
|
||||||||||||||||||||
Total net increase (decrease) in net assets from capital transactions
|
||||||||||||||||||||
Total increase (decrease) in net assets
|
( |
) | ( |
) | ||||||||||||||||
Balance, September 30, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Common Stock
|
||||||||||||||||||||
Three Months Ended
September 30, 2023
|
Shares
|
Par value
|
Additional
paid-in-capital |
Distributable Earnings/
(Accumulated Loss) |
Total
net assets
|
|||||||||||||||
Balance, June 30, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
Net increase (decrease) in net assets resulting from operations
|
||||||||||||||||||||
Net investment income (loss)
|
-
|
|
|
|
|
|||||||||||||||
Net realized gain (loss) from investments
|
-
|
|
|
|
|
|||||||||||||||
Net change in unrealized appreciation (depreciation) from investments
|
-
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Total net increase (decrease) in net assets resulting from operations
|
-
|
|
|
|
|
|||||||||||||||
Distributions to stockholders from: |
||||||||||||||||||||
Investment income-net
|
- | ( |
) | ( |
) | |||||||||||||||
Capital transactions
|
||||||||||||||||||||
Reinvestment of stockholder distributions
|
||||||||||||||||||||
Total net increase (decrease) in net assets from capital transactions
|
||||||||||||||||||||
Total increase (decrease) in net assets
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Balance, September 30, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Common Stock
|
|||||||||||||||||||
Nine Months Ended
September 30, 2024 |
Shares
|
Par Value
|
Additional
paid-in-capital |
Distributable Earnings/
(Accumulated Loss)
|
Total
net assets
|
|||||||||||||||
Balance, December 31, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
Net increase (decrease) in net assets resulting from operations
|
||||||||||||||||||||
Net investment income (loss)
|
-
|
|
|
|
|
|||||||||||||||
Net realized gain (loss) from investments
|
-
|
|
|
|
|
|||||||||||||||
Net change in unrealized appreciation (depreciation) from investments
|
-
|
|
|
|
|
|||||||||||||||
Total net increase (decrease) in net assets resulting from operations
|
-
|
|
|
|
|
|||||||||||||||
Distributions to stockholders from:
|
||||||||||||||||||||
Investment income-net
|
- | ( |
) | ( |
) | |||||||||||||||
Capital transactions
|
||||||||||||||||||||
Reinvestment of stockholder distributions
|
||||||||||||||||||||
Total net increase (decrease) in net assets from capital transactions
|
||||||||||||||||||||
Total increase (decrease) in net assets
|
( |
) | ( |
) | ||||||||||||||||
Effect of permanent adjustments |
- | ( |
) | |||||||||||||||||
Balance, September 30, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Common Stock
|
||||||||||||||||||||
Nine Months Ended
September 30, 2023 |
Shares
|
Par value
|
Additional
paid-in-capital |
Distributable Earnings/
(Accumulated Loss)
|
Total
net assets
|
|||||||||||||||
Balance, December 31, 2022
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
Net increase (decrease) in net assets resulting from operations
|
||||||||||||||||||||
Net investment income (loss)
|
-
|
|
|
|
|
|||||||||||||||
Net realized gain (loss) from investments
|
-
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Net change in unrealized appreciation (depreciation) from investments
|
-
|
|
|
|
|
|||||||||||||||
Total net increase (decrease) in net assets resulting from operations
|
-
|
|
|
|
|
|||||||||||||||
Distributions to stockholders from:
|
||||||||||||||||||||
Investment income-net
|
- | ( |
) | ( |
) | |||||||||||||||
Capital transactions
|
||||||||||||||||||||
Issuance of common stock
|
|
|
|
|
|
|||||||||||||||
Reinvestment of stockholder distributions
|
||||||||||||||||||||
Total net increase (decrease) in net assets from capital transactions
|
||||||||||||||||||||
Total increase (decrease) in net assets
|
|
|
|
|
|
|||||||||||||||
Effect of permanent adjustments
|
-
|
|
|
(
|
)
|
|
||||||||||||||
Balance, September 30, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
For the nine months ended
|
|||||||
|
September 30, 2024
|
September 30, 2023
|
||||||
Cash flows from operating activities
|
||||||||
Net increase (decrease) in net assets resulting from operations
|
$
|
|
$
|
|
||||
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
|
||||||||
Net realized (gain) loss from investments
|
||||||||
Net change in unrealized (appreciation) depreciation from investments
|
(
|
)
|
(
|
)
|
||||
Net (accretion of discounts) and amortization of premiums
|
(
|
)
|
(
|
)
|
||||
Purchase of investments
|
(
|
)
|
(
|
)
|
||||
PIK interest capitalized
|
( |
) | ( |
) | ||||
Proceeds from sales of investments and principal repayments
|
||||||||
(Increase)/Decrease in operating assets:
|
||||||||
Other receivable
|
( |
) | ||||||
Interest receivable
|
|
(
|
)
|
|||||
Paydown receivable
|
( |
) | ||||||
Prepaid expenses
|
(
|
)
|
(
|
)
|
||||
Other assets
|
( |
) | ||||||
Increase/(Decrease) in operating liabilities:
|
||||||||
Income-based incentive fees payable
|
(
|
)
|
|
|||||
Management fee payable
|
( |
) | ||||||
Capital gains incentive fees payable
|
||||||||
Legal fees payable
|
||||||||
Transaction fees payable related to the Loan Portfolio Acquisition
|
||||||||
Valuation fees payable
|
(
|
)
|
|
|||||
Administrator fees payable
|
(
|
)
|
|
|||||
Audit fees payable
|
|
|||||||
Directors fees payable
|
(
|
)
|
|
|||||
Professional fees payable
|
|
(
|
)
|
|||||
Other payables
|
|
(
|
)
|
|||||
Unearned interest income
|
||||||||
Due to affiliate
|
||||||||
Excise tax payable
|
( |
) |
(
|
)
|
||||
Net cash provided by (used in) operating activities
|
|
(
|
)
|
|||||
|
||||||||
Cash flows from financing activities
|
||||||||
Offering costs paid
|
( |
) | ||||||
Distributions paid
|
( |
) | ( |
) | ||||
Net cash provided by (used in) financing activities
|
(
|
)
|
(
|
)
|
||||
|
||||||||
Net increase (decrease) in cash and cash equivalents
|
(
|
)
|
(
|
)
|
||||
Cash and cash equivalents, beginning of period
|
|
|
||||||
Cash and cash equivalents, end of period
|
$
|
|
$
|
|
||||
Supplemental and non-cash financing activities |
||||||||
Reinvestment of dividend distributions
|
$ | $ | ||||||
Accrual for deferred financing costs (Note 2)
|
$ | $ | ||||||
Accrual for deferred offering costs (Note 2)
|
$ | $ |
Portfolio Company (1)(10)(13)
|
Type of Investment (2)
|
Investment
Date (3)
|
Maturity Date
|
Interest Rate (4)
|
Fair Value
Hierarchy (5)
|
Geographic
Region (6) |
Non-
Qualifying
Asset (7)
|
Principal
Amount (8)
|
Amortized
Cost
|
Fair Value (9)
|
% of Net
Assets
|
|||||||||||||||
Debt Securities - United States
|
||||||||||||||||||||||||||
Real Estate Services
|
||||||||||||||||||||||||||
|
Fixed interest rate |
No | $ | $ | $ | % | ||||||||||||||||||||
Wholesale Trade |
||||||||||||||||||||||||||
|
Fixed interest rate |
No
|
||||||||||||||||||||||||
|
|
|
|
Fixed interest rate
|
|
|
Yes
|
|
|
|
|
|||||||||||||||
(d/b/a Jeeter)
|
|
|
|
Variable interest rate PRIME(11) + |
No
|
|
||||||||||||||||||||
|
|
|
|
Fixed interest rate
|
|
|
No
|
|
|
|
|
|||||||||||||||
(f/k/a Shryne Group Inc.)
|
|
|
|
Variable interest rate PRIME(11) +
( |
|
|
No
|
|
|
|
|
|||||||||||||||
|
|
|
|
Variable interest rate PRIME(11) +
( |
|
|
Yes
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
||||||||||||||||||||||
|
||||||||||||||||||||||||||
Total: Debt Securities - United States (
|
|
|
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||
Total: Debt Securities (
|
|
|
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||
Equity Securities - United States |
Shares/
Units
|
|||||||||||||||||||||||||
Real Estate Services
|
||||||||||||||||||||||||||
|
$ | $ | % | |||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Total: Equity Securities - United States (
|
||||||||||||||||||||||||||
Total: Equity Securities (
|
||||||||||||||||||||||||||
$
|
|
$
|
|
|
% | |||||||||||||||||||||
Cash Equivalents
|
||||||||||||||||||||||||||
State Street Institutional U.S. Government Money Market Fund (12)
|
$
|
|
$
|
|
|
%
|
||||||||||||||||||||
Cash Equivalents (
|
|
|
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||
Total Portfolio Investments and Cash Equivalents (
|
$
|
|
$
|
|
|
%
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
(5) |
|
(6) |
|
(7) |
|
(8) |
|
(9) |
|
(10) |
|
(11) |
|
(12) |
|
(13) |
(in millions)
Portfolio Company |
Total loan commitments
|
Less: funded commitments
|
Total unfunded
commitments
|
Less: commitments
substantially at discretion
of the Company
|
Less: unavailable
commitments due to
borrowing base or other
covenant restrictions
|
Total net
commitments
|
||||||||||||||||||
Workbox Holdings, Inc.
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Portfolio Company (1)
|
Type of Investment (2)
|
Investment
Date (3)
|
Maturity Date
|
Interest Rate (4)
|
Fair Value
Hierarchy (5) |
Geographic
Region (6) |
Non-
Qualifying
Asset (7)
|
Principal
Amount (8)
|
Amortized
Cost
|
Fair Value (9)
|
% of
Net Assets
|
|||||||||||||||
Debt Securities - United States
|
|
|
|
|
|
|||||||||||||||||||||
Wholesale Trade (10)
|
|
|
||||||||||||||||||||||||
|
|
|
|
Fixed interest rate |
|
|
Yes
|
$ |
|
$ |
|
$ |
|
% |
||||||||||||
(d/b/a Jeeter)
|
Variable interest rate PRIME(11) + |
No | ||||||||||||||||||||||||
|
|
|
|
Fixed interest rate
|
|
|
No
|
|
|
|
|
|||||||||||||||
(f/k/a Shryne Group Inc.)
|
|
|
|
Variable interest rate PRIME(11) +
( |
|
|
No
|
|
|
|
|
|||||||||||||||
|
|
|
|
Variable interest rate PRIME(11) +
( |
|
|
Yes
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
$
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||
Total: Debt Securities - United States (
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||
Total: Debt Securities (
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||
Investment in Securities (
|
|
|
$
|
|
$
|
|
|
%
|
||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||
Cash Equivalents
|
|
|
||||||||||||||||||||||||
State Street Institutional U.S. Government Money Market Fund (12)
|
|
|
|
$
|
|
$
|
|
|
%
|
|||||||||||||||||
Cash Equivalents (
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||
Total Portfolio Investments and Cash Equivalents (
|
|
|
$
|
|
$
|
|
|
%
|
(1) |
All portfolio companies are located in the United States, as determined by the location of the portfolio company’s headquarters.
|
(2) |
|
(3) |
Investment date represents the date of initial investment, at which date interest began accruing.
|
(4) |
Interest rate is the fixed or variable rate of the debt investments.
|
(5) |
See Note 2 – Significant Accounting Policies and Note 4 — Fair Value of Financial Instruments in the accompanying notes to the financial statements.
|
(6) |
Geographic regions are determined by the respective portfolio company’s headquarters’ location.
|
(7) |
Under the Investment Company Act of 1940, as amended (the “1940 Act”), a business development company (“BDC”) may not acquire any “non-qualifying asset” (i.e., an asset other than assets of the type listed in Section 55(a) of the 1940
Act, which are referred to as “qualifying assets”), unless, at the time the acquisition is made, qualifying assets represent at least 70% of the BDC’s total assets. As of December 31, 2023 the aggregate fair value of non-qualifying assets
is $
|
(8) |
Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.
|
(9) |
All investments were valued at fair value. See Note 4 — Fair Value of Financial Instruments in the accompanying notes to the financial statements.
|
(10) |
The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.
|
(11) |
|
(12) |
|
• |
With respect to investments for which market quotations are readily available, those investments will typically be valued at the bid price of those market quotations;
|
• |
With respect to investments for which market quotations are not readily available, the valuation process begins with the Adviser’s valuation committee establishing a preliminary valuation of each investment, which may be based on
valuations, or ranges of valuations, provided by independent valuation firm(s);
|
• |
Preliminary valuations are documented and discussed by the Adviser’s valuation committee and, where appropriate, the independent valuation firm(s); and
|
• |
The Adviser determines the fair value of each investment.
|
• |
Level 1 – Valuations based on quoted prices in active markets for identical assets or liabilities that we have the ability to access at the measurement date;
|
• |
Level 2 – Valuations based on quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not
active, or for which all significant inputs are observable, either directly or indirectly; and
|
• |
Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
September 30, 2024
|
||||||||||||||||
Amortized Cost
|
Fair Value
|
|||||||||||||||
Industry
|
Amount
|
%
|
Amount
|
%
|
||||||||||||
Wholesale Trade
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
Real Estate Services |
||||||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
December 31, 2023
|
||||||||||||||||
Amortized Cost
|
Fair Value
|
|||||||||||||||
Industry
|
Amount
|
%
|
Amount
|
%
|
||||||||||||
Wholesale Trade
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
September 30, 2024
|
||||||||||||||||
Amortized Cost
|
Fair Value
|
|||||||||||||||
Geographic Location
|
Amount
|
%
|
Amount
|
%
|
||||||||||||
West
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
Midwest
|
|
|
|
|
||||||||||||
Northeast
|
|
|
|
|
||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
December 31, 2023
|
||||||||||||||||
Amortized Cost
|
Fair Value
|
|||||||||||||||
Geographic Location
|
Amount
|
%
|
Amount
|
%
|
||||||||||||
West
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
Midwest
|
|
|
|
|
||||||||||||
Northeast
|
|
|
|
|
||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
September 30, 2024
|
||||||||||||||||
Amortized Cost
|
Fair Value
|
|||||||||||||||
Investment
|
Amount
|
%
|
Amount
|
%
|
||||||||||||
Senior Secured First Lien Term Loans
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
Senior Secured Notes
|
|
|
|
|
||||||||||||
Equity |
||||||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
December 31, 2023 | ||||||||||||||||
Amortized Cost
|
Fair Value
|
|||||||||||||||
Investment
|
Amount
|
%
|
Amount
|
%
|
||||||||||||
Senior Secured First Lien Term Loans
|
$
|
|
|
%
|
$
|
|
|
%
|
||||||||
Senior Secured Notes
|
|
|
|
|
||||||||||||
Total
|
$
|
|
|
%
|
$
|
|
|
%
|
•
|
The cannabis industry is extremely speculative and raises a host of legality issues, making it subject to inherent risk;
|
•
|
The manufacture, distribution, sale, or possession of cannabis that is not in compliance with the U.S. Controlled Substances Act is illegal
under U.S. federal law. Strict enforcement of U.S. federal laws regarding cannabis would likely result in our portfolio companies’ inability to execute a business plan in the cannabis industry, and could result in the loss of all or
part of any of our loans;
|
•
|
The Biden Administration’s or specifically the U.S. Department of Justice’s change in policies or enforcement with respect to U.S. federal
cannabis laws could negatively impact our portfolio companies’ ability to pursue their prospective business operations and/or generate revenues;
|
•
|
U.S. federal courts may refuse to recognize the enforceability of contracts pertaining to any business operations that are deemed illegal
under U.S. federal law, including cannabis companies operating legally under state law;
|
•
|
Consumer complaints and negative publicity regarding cannabis-related products and services could lead to political pressure on states to
implement new laws and regulations that are adverse to the cannabis industry, to not modify existing, restrictive laws and regulations, or to reverse current favorable laws and regulations relating to cannabis;
|
•
|
Assets collateralizing loans to cannabis businesses may be forfeited to the U.S. federal government in connection with government enforcement
actions under U.S. federal law;
|
•
|
U.S. Food and Drug Administration regulation of cannabis and the possible registration of facilities where cannabis is grown could negatively
affect the cannabis industry, which could directly affect our financial condition and the financial condition of our portfolio companies;
|
•
|
Due to our proposed strategy of investing in portfolio companies engaged in the regulated cannabis industry, our portfolio companies may have
a difficult time obtaining the various insurance policies that are needed to operate such businesses, which may expose us and our portfolio companies to additional risks and financial liabilities;
|
•
|
The cannabis industry may face significant opposition from other industries that perceive cannabis products and services as competitive with
their own, including but not limited to the pharmaceutical industry, adult beverage industry and tobacco industry, all of which have powerful lobbying and financial resources;
|
•
|
Many national and regional banks have been resistant to doing business with cannabis companies because of the uncertainties presented by
federal law and, as a result, we or our portfolio companies may have difficulty borrowing from or otherwise accessing the service of banks, which may inhibit our ability to open bank accounts or otherwise utilize traditional banking
services;
|
•
|
Due to our proposed strategy of investing in portfolio companies engaged in the regulated cannabis industry, we or our portfolio companies
may have a difficult time obtaining financing in connection with our investment strategy; and
|
•
|
Laws and regulations affecting the regulated cannabis industry are varied, broad in scope and subject to evolving interpretations, and may
restrict the use of the properties our portfolio companies acquire or require certain additional regulatory approvals, which could materially adversely affect our investments in such portfolio companies.
|
Fair Value Measurements at September 30, 2024 Using
|
||||||||||||||||
Assets
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
Significant
Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
Senior Secured First Lien Term Loans
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Senior Secured Notes
|
|
|
|
|
||||||||||||
Equity |
||||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
Fair Value Measurements at December 31, 2023 Using
|
||||||||||||||||
Assets
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
Significant
Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
Senior Secured First Lien Term Loans
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Senior Secured Notes
|
|
|
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
Investment Type
|
Fair Value as of
September 30, 2024 |
Valuation Techniques/
Methodologies
|
Unobservable Input
|
Range
|
Weighted Average (1)
|
||||||||||
Senior Secured First Lien Term Loans
|
$
|
|
Discounted Cash Flow
|
Discount Rate
|
|
%
|
|
%
|
|||||||
Senior Secured Notes
|
|
Discounted Cash Flow
|
Discount Rate
|
|
%
|
|
%
|
||||||||
Preferred Equity Securities |
Enterprise Value Market Approach
|
Enterprise Valuation Multiple |
x |
x | |||||||||||
Warrants and Other Equity Securities |
Option Pricing Model |
Volatility Factor | % | % | |||||||||||
Total
|
$
|
|
Investment Type
|
Fair Value as of
December 31, 2023
|
Valuation Techniques/
Methodologies
|
Unobservable Input
|
Range
|
Weighted Average (1)
|
||||||||||
Senior Secured First Lien Term Loans
|
$
|
|
Discounted Cash Flow
|
Discount Rate
|
|
%
|
|
%
|
|||||||
Senior Secured Notes
|
|
Discounted Cash Flow
|
Discount Rate
|
|
%
|
|
%
|
||||||||
Total
|
$
|
|
Senior Secured
First Lien Term Loans |
Senior
Secured Notes |
Equity |
Total
Investments |
|||||||||||||
Fair Value as of December 31, 2023
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||
Purchases
|
|
|
|
|||||||||||||
Accretion of discount and fees (amortization of premium), net
|
|
|
|
|||||||||||||
PIK interest |
||||||||||||||||
Proceeds from sales of investments and principal repayments
|
(
|
)
|
|
(
|
)
|
|||||||||||
Net realized gain (loss) on investments
|
|
|
|
|||||||||||||
Net change in unrealized appreciation (depreciation) from investments
|
|
|
( |
) |
|
|||||||||||
Balance as of September 30, 2024
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||
|
||||||||||||||||
Net change in unrealized appreciation/depreciation on Level 3 investments still held as of September 30, 2024
|
$
|
|
$
|
|
$ | ( |
) |
$
|
|
Senior Secured
First Lien Term Loans |
Senior Secured Notes |
Total
Investments |
||||||||||
Fair Value as of December 31, 2022
|
$
|
|
$ |
$
|
|
|||||||
Purchases
|
|
|
||||||||||
Accretion of discount and fees (amortization of premium), net
|
|
|
||||||||||
PIK interest
|
|
|
||||||||||
Proceeds from sales of investments and principal repayments
|
(
|
)
|
( |
) |
(
|
)
|
||||||
Net realized gain (loss) on investments
|
|
( |
) |
(
|
)
|
|||||||
Net change in unrealized appreciation (depreciation) on investments
|
|
( |
) |
|
||||||||
Balance as of September 30, 2023
|
$
|
|
$ |
$
|
|
|||||||
Net change in unrealized appreciation/depreciation on Level 3 investments still held as of September 30, 2023
|
$
|
|
$ | ( |
) |
$
|
|
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Per Share
Amount |
Dividends Paid
|
|||||||||
|
|
|
|
$
|
|
$
|
|
|||||||
$ | $ | |||||||||||||
$ | $ |
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Per Share
Amount |
Dividends Paid
|
|||||||||
|
|
|
|
$
|
|
$
|
|
|||||||
$ | $ |
Declaration Date |
Type |
Record Date
|
Payment Date
|
Shares
|
||||||
|
|
|
|
|||||||
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Shares
|
||||||
|
|
|
|
|
|
|||||
Three Months Ended
September 30, 2024
|
Three Months Ended
September 30, 2023
|
Nine Months Ended
September 30, 2024
|
Nine Months Ended
September 30, 2023
|
|||||||||||||
Net increase (decrease) in net assets resulting from operations
|
$
|
(
|
)
|
$
|
|
$ | $ | |||||||||
Weighted Average Shares Outstanding — basic and diluted
|
|
|
||||||||||||||
Net increase (decrease) in net assets resulting from operations per share — basic and diluted
|
$
|
(
|
)
|
$
|
|
$ | $ |
|
For the tax period from April 1, 2024
through September 30, 2024
|
For the tax year from April 1, 2023
through March 31, 2024
|
||||||
Ordinary income
|
$
|
|
$
|
|
||||
|
|
March 31, 2024
|
March 31, 2023 | |||||||
Undistributed ordinary income
|
$
|
|
$ |
|||||
Net unrealized appreciation (depreciation) on investments
|
|
|
||||||
Capital loss carry forwards |
|
( |
) | |||||
Other temporary differences
|
|
(
|
)
|
|
( |
) | ||
Total
|
$
|
(
|
)
|
$ |
September 30, 2024 |
March 31, 2024 |
December 31, 2023
|
||||||||||
Tax cost of investments and cash equivalents
|
$ | $ |
$
|
|
||||||||
Unrealized appreciation
|
$ | $ |
$
|
|
||||||||
Unrealized depreciation
|
$ | ( |
) | $ | ( |
) |
$
|
(
|
)
|
|||
Net unrealized appreciation (depreciation) from investments and cash equivalents
|
$ | $ |
|
|
For the nine months ended
|
||||||||
September 30, 2024
|
September 30, 2023
|
|||||||
Per share data:
|
||||||||
Net asset value at beginning of period
|
$
|
|
$
|
|
||||
Net investment income (loss) (1)
|
|
|
||||||
Net realized and unrealized gains/(losses) on investments (1)
|
|
(
|
)
|
|||||
Net increase/(decrease) in net assets resulting from operations
|
|
|
||||||
Distributions from net investment income (loss) (4) |
( |
) | ( |
) | ||||
Net asset value at end of period
|
$
|
|
$
|
|
||||
Net assets at end of period
|
$
|
|
$
|
|
||||
Shares outstanding at end of period
|
|
|
||||||
Weighted average net assets
|
$
|
|
$
|
|
||||
|
||||||||
Per share market value at end of period
|
$
|
|
$
|
|
||||
Total return based on market value (2)
|
|
%
|
(
|
)%
|
||||
Total return based on net asset value (2)
|
|
%
|
|
%
|
||||
|
||||||||
Ratio/Supplemental data:
|
||||||||
Ratio of expenses to average net assets (3)
|
|
%
|
|
%
|
||||
Ratio of net investment income (loss) to average net assets (3)
|
|
%
|
|
%
|
||||
Portfolio turnover (3)
|
|
%
|
|
%
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
Issuer
|
Industry
|
Instrument
|
Reference Rate
|
Floor
|
Spread
|
Total Coupon
|
Maturity
|
Principal
|
Transaction
Fair Value (k)
|
||||||||||||
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
$ |
|
$ |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
Fixed |
n/a
|
n/a
|
|
|
|
|
||||||||||||
|
|
|
Fixed |
n/a
|
n/a
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
n/a
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
Fixed |
n/a
|
n/a
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
Fixed |
n/a
|
n/a
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
Fixed |
n/a
|
n/a |
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
$ |
|
$ |
|
(a) |
|
(b) |
|
(c) |
|
(d) |
|
(e) |
|
(f) |
|
(g) |
|
(h) |
|
(i) |
|
(j)
|
|
(k)
|
|
(l)
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
•
|
Growth or EBITDA positive entities
|
•
|
Companies that require capital but do not want to dilute their equity
|
•
|
Companies that are showing strong cash flow performance with low leverage profiles
|
•
|
Transactions tend to be attractively priced and have better than normal covenants and amortization due to complexity of the industry
|
•
|
Low debt to enterprise value
|
•
|
Industry leaders and disruptive companies experiencing strong growth
|
•
|
Companies that have raised significant equity capital validating market value
|
•
|
Industry focus typically includes software, hardware, e-commerce and direct to consumer
|
•
|
Liquidity covenants that ensure such company has adequate cash runway
|
•
|
Low debt to enterprise value
|
•
|
Profitable or demonstrated path to near term profitability
|
•
|
Structured credit and asset-based loans, receivables pools and equipment
|
•
|
Companies that are showing strong cash flow performance with low leverage profiles, but the industries carry regulatory, reputational or other
risks
|
•
|
Transactions tend to be attractively priced and have better than normal covenants and amortization due to complexity of the industry or
situation
|
•
|
Low debt to asset values and/or enterprise values
|
•
|
Financing is typically event driven
|
•
|
Companies that are pursuing a merger, acquisition, refinancing, dividend recap, or other strategic liquidity need
|
•
|
Companies that are showing strong cash flow performance with low leverage profiles
|
•
|
Companies that have multiple areas of value and liquidity in addition to the underlying business
|
•
|
Low debt to enterprise value
|
•
|
Industry agnostic
|
• |
the cost of our organization and offerings;
|
• |
the cost of calculating our NAV, including the cost of any third-party valuation services;
|
• |
the cost of effecting sales and repurchases of shares of our common stock and other securities;
|
• |
fees and expenses payable under any underwriting agreements, if any;
|
• |
debt service and other costs of borrowings or other financing arrangements;
|
• |
costs of hedging;
|
• |
expenses, including travel expenses, incurred by the Adviser, or members of the investment team, or payable to third-parties, performing due diligence on prospective portfolio companies and, if necessary, enforcing
our rights;
|
• |
management and incentive fees payable pursuant to the Investment Advisory Agreement;
|
• |
fees payable to third-parties relating to, or associated with, making investments and valuing investments (including third-party valuation firms);
|
• |
costs, including legal fees, associated with compliance under cannabis laws;
|
• |
transfer agent and custodial fees;
|
• |
fees and expenses associated with marketing efforts (including attendance at industry and investor conferences and similar events);
|
• |
federal and state registration fees;
|
• |
any exchange listing fees and fees payable to rating agencies;
|
• |
federal, state and local taxes;
|
• |
independent directors’ fees and expenses, including travel expenses;
|
• |
cost of preparing financial statements and maintaining books and records and filing reports or other documents with the SEC (or other regulatory bodies) and other reporting and compliance costs, and the compensation
of professionals responsible for the preparation of the foregoing;
|
• |
the cost of any reports, proxy statements or other notices to our stockholders (including printing and mailing costs), the costs of any stockholder or director meetings and the compensation of investor relations
personnel responsible for the preparation of the foregoing and related matters;
|
• |
brokerage commissions and other compensation payable to brokers or dealers;
|
• |
research and market data;
|
• |
fidelity bond, directors’ and officers’ errors and omissions liability insurance and other insurance premiums;
|
• |
direct costs and expenses of administration, including printing, mailing and staff;
|
• |
fees and expenses associated with independent audits, and outside legal and consulting costs;
|
• |
costs of winding up;
|
• |
costs incurred in connection with the formation or maintenance of entities or vehicles to hold our assets for tax or other purposes;
|
• |
extraordinary expenses (such as litigation or indemnification); and
|
• |
costs associated with reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws.
|
September 30, 2024
|
||||||||
Type
|
Amortized Cost
|
Fair Value
|
||||||
Senior Secured First Lien Term Loans
|
77.5
|
%
|
77.7
|
%
|
||||
Senior Secured Notes
|
21.1
|
21.1
|
||||||
Equity
|
1.4
|
1.2
|
||||||
Total
|
100.0
|
%
|
100.0
|
%
|
December 31, 2023
|
||||||||
Type
|
Amortized Cost
|
Fair Value
|
||||||
Senior Secured First Lien Term Loans
|
84.9
|
%
|
85.0
|
%
|
||||
Senior Secured Notes
|
15.1
|
15.0
|
||||||
Total
|
100.0
|
%
|
100.0
|
%
|
September 30, 2024
|
||||||||
Geographic Region
|
Amortized Cost
|
Fair Value
|
||||||
West
|
43.8
|
%
|
43.3
|
%
|
||||
Midwest
|
42.7
|
43.0
|
||||||
Northeast
|
13.5
|
13.7
|
||||||
Total
|
100.0
|
%
|
100.0
|
%
|
December 31, 2023
|
||||||||
Geographic Region
|
Amortized Cost
|
Fair Value
|
||||||
West
|
46.5
|
%
|
46.4
|
%
|
||||
Midwest
|
46.0
|
46.0
|
||||||
Northeast
|
7.5
|
7.6
|
||||||
Total
|
100.0
|
%
|
100.0
|
%
|
September 30, 2024
|
||||||||
Industry
|
Amortized Cost
|
Fair Value
|
||||||
Wholesale Trade
|
96.6
|
%
|
96.5
|
%
|
||||
Real Estate Services
|
3.4
|
3.5
|
||||||
Total
|
100.0
|
%
|
100.0
|
%
|
December 31, 2023
|
||||||||
Industry
|
Amortized Cost
|
Fair Value
|
||||||
Wholesale Trade
|
100.0
|
%
|
100.0
|
%
|
||||
Total
|
100.0
|
%
|
100.0
|
%
|
Nine Months Ended
|
Nine Months Ended
|
|||||||
September 30, 2024
|
September 30, 2023
|
|||||||
Beginning Portfolio, at fair value
|
$
|
54,120,000
|
$
|
50,254,550
|
||||
Purchases
|
5,141,250
|
8,442,000
|
||||||
Accretion of discount and fees (amortization of premium), net
|
501,303
|
431,052
|
||||||
PIK interest
|
182,634
|
78,153
|
||||||
Proceeds from sales of investments and principal repayments
|
(4,344,000
|
)
|
(1,780,000
|
)
|
||||
Net realized gain/(loss) on investments
|
-
|
(210,767
|
)
|
|||||
Net change in unrealized appreciation/(depreciation) on investments
|
187,324
|
166,012
|
||||||
Ending Portfolio, at fair value
|
$
|
55,788,511
|
$
|
57,381,000
|
Investment
Performance
Risk Rating
|
Summary Description
|
|
Grade 1
|
Investments rated 1 involve the least amount of risk to our initial cost basis. The borrower is performing above expectations, and the trends and risk factors for this investment since origination or acquisition are
generally favorable. Full return of principal, interest and dividend income is expected.
|
|
Grade 2
|
Investment is performing in-line with expectations. Investments rated 2 involve an acceptable level of risk that is similar to the risk at the time of origination or acquisition. Risk factors remain neutral or
favorable compared with initial underwriting. All investments or acquired investments in new portfolio companies are initially assessed a rating of 2.
|
|
Grade 3
|
Investments rated 3 involve a borrower performing below expectations and indicates that the loan’s risk has increased somewhat since origination or acquisition. Capital impairment or payment delinquency is not
anticipated. The investment may also be out of compliance with certain financial covenants.
|
|
Grade 4
|
Investments rated 4 involve a borrower performing materially below expectations and indicates that the loan’s risk has increased materially since origination or acquisition. In addition to the borrower being
generally out of compliance with debt covenants, loan payments may be past due (but generally not more than 120 days past due). Delinquency of interest and / or dividend payments in anticipated. No loss of principal is anticipated.
|
|
Grade 5
|
Investments rated 5 involve a borrower performing substantially below expectations and indicates that the loan’s risk has increased substantially since origination or acquisition. It is anticipated that the Company
will not recoup its initial cost and may realize a loss upon exit. Most or all of the debt covenants are out of compliance and payments are substantially delinquent. Loans rated 5 are not anticipated to be repaid in full and we will reduce
the fair market value of the loan to the amount we anticipate will be recovered.
|
September 30, 2024
|
|||||||||
Investment Performance Risk Rating
|
Investments at Fair
Value
|
Percentage of Total
Investments
|
|||||||
1
|
$
|
-
|
-
|
%
|
|||||
2
|
55,788,511
|
100.00
|
|||||||
3
|
-
|
-
|
|||||||
4
|
-
|
-
|
|||||||
5
|
-
|
-
|
|||||||
Total
|
$
|
55,788,511
|
100.00
|
%
|
December 31, 2023
|
|||||||||
Investment Performance Risk Rating
|
Investments at Fair
Value |
Percentage of Total
Investments
|
|||||||
1
|
$
|
-
|
-
|
%
|
|||||
2
|
54,120,000
|
100.00
|
|||||||
3
|
-
|
-
|
|||||||
4
|
-
|
-
|
|||||||
5
|
-
|
-
|
|||||||
Total
|
$
|
54,120,000
|
100.00
|
%
|
Three Months Ended
|
Three Months Ended
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||
September 30, 2024
|
September 30, 2023
|
September 30, 2024
|
September 30, 2023
|
|||||||||||||
Stated interest income
|
$
|
2,465,150
|
$
|
2,740,665
|
$
|
7,519,664
|
$
|
7,596,808
|
||||||||
Accretion of discount and fees (amortization of premium), net
|
152,124
|
129,494
|
501,303
|
431,052
|
||||||||||||
Payment in-kind interest
|
69,497
|
15,566
|
182,634
|
78,153
|
||||||||||||
Total interest income
|
2,686,771
|
2,885,725
|
8,203,601
|
8,106,013
|
||||||||||||
Fee income
|
489,176
|
31,250
|
813,926
|
162,500
|
||||||||||||
Total investment income
|
$
|
3,175,947
|
$
|
2,916,975
|
$
|
9,017,527
|
$
|
8,268,513
|
|
For the Nine
months ended |
For the Nine
months ended |
||||||||||||||
|
September 30, 2024
|
September 30, 2023
|
$ Change
|
% Change
|
||||||||||||
Transaction expenses related to the Loan Portfolio Acquisition
|
$
|
5,069,062
|
$
|
-
|
$
|
5,069,062
|
100
|
%
|
||||||||
Management fee
|
745,876
|
760,473
|
(14,597
|
)
|
-2
|
%
|
||||||||||
Income-based incentive fees
|
328,503
|
1,051,741
|
(723,238
|
)
|
-69
|
%
|
||||||||||
Audit expense
|
299,225
|
409,365
|
(110,140
|
)
|
-27
|
%
|
||||||||||
Administrator fees
|
298,132
|
250,314
|
47,818
|
19
|
%
|
|||||||||||
Legal expenses
|
200,073
|
334,308
|
(134,235
|
)
|
-40
|
%
|
||||||||||
Insurance expense
|
199,430
|
202,597
|
(3,167
|
)
|
-2
|
%
|
||||||||||
Other expenses
|
107,213
|
61,918
|
45,295
|
73
|
%
|
|||||||||||
Director expenses
|
80,311
|
105,913
|
(25,602
|
)
|
-24
|
%
|
||||||||||
Professional fees
|
74,694
|
51,808
|
22,886
|
44
|
%
|
|||||||||||
Valuation fees
|
50,043
|
116,955
|
(66,912
|
)
|
-57
|
%
|
||||||||||
Capital gains incentive fees
|
37,465
|
-
|
37,465
|
100
|
%
|
|||||||||||
Custodian fees
|
35,850
|
36,000
|
(150
|
)
|
0
|
%
|
||||||||||
Excise tax expense
|
31,314
|
-
|
31,314
|
100
|
%
|
|||||||||||
Total expenses
|
$
|
7,557,191
|
$
|
3,381,392
|
$
|
4,175,799
|
123
|
%
|
Three Months Ended
|
Three Months Ended
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||
September 30, 2024
|
September 30, 2023
|
September 30, 2024
|
September 30, 2023
|
|||||||||||||
Gross unrealized appreciation
|
$
|
101,825
|
$
|
-
|
$
|
282,329 |
$
|
365,811
|
||||||||
Gross unrealized depreciation
|
(281,349
|
)
|
(343,104
|
)
|
(95,005
|
)
|
(199,799
|
)
|
||||||||
Total net change in unrealized appreciation (depreciation) from investments
|
$
|
(179,524
|
)
|
$
|
(343,104
|
)
|
$
|
187,324
|
$
|
166,012
|
Three Months Ended
|
Three Months Ended
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||
September 30, 2024
|
September 30, 2023
|
September 30, 2024
|
September 30, 2023
|
|||||||||||||
Verano Holdings Corp.
|
$
|
(33,696
|
)
|
$
|
(33,861
|
)
|
$
|
13,915
|
$
|
90,950
|
||||||
STIIIZY, Inc. (f/k/a Shryne Group Inc.)
|
(134,430
|
)
|
(129,301
|
)
|
(2,750
|
)
|
212,530
|
|||||||||
Curaleaf Holdings, Inc.
|
50,692
|
(45,744
|
)
|
45,173
|
62,331
|
|||||||||||
MariMed Inc.
|
-
|
(39,029
|
)
|
-
|
(8,165
|
)
|
||||||||||
Dreamfields Brands, Inc. (d/b/a Jeeter)
|
(8,223
|
)
|
(32,298
|
)
|
(25,429
|
)
|
(32,220
|
)
|
||||||||
PharmaCann, Inc.
|
40,560
|
(62,871
|
)
|
81,842
|
(159,414
|
)
|
||||||||||
Workbox Holdings, Inc.
|
10,573 |
|
141,399 |
|
-
|
|||||||||||
Workbox Holdings, Inc, A-1 Preferred | - | - |
-
|
|||||||||||||
Workbox Holdings, Inc: A-3 Warrants | (41,000 |
)
|
-
|
(25,785
|
)
|
-
|
||||||||||
Workbox Holdings, Inc: A-4 Warrants |
(64,000 |
) |
(41,041 |
) |
||||||||||||
Ascend Wellness Holdings, Inc.
|
-
|
-
|
-
|
-
|
||||||||||||
Total net change in unrealized appreciation (depreciation) on investments
|
$
|
(179,524
|
)
|
$
|
(343,104
|
)
|
$
|
187,324
|
$
|
166,012
|
• |
With respect to investments for which market quotations are readily available, those investments will typically be valued at the bid price of those market quotations;
|
• |
With respect to investments for which market quotations are not readily available, the valuation process begins with the Adviser’s valuation committee establishing a preliminary valuation of each investment, which
may be based on valuations, or ranges of valuations, provided by independent valuation firm(s);
|
• |
Preliminary valuations are documented and discussed by the Adviser’s valuation committee and, where appropriate, the independent valuation firm(s); and
|
• |
The Adviser determines the fair value of each investment.
|
• |
Level 1 – Valuations based on quoted prices in active markets for identical assets or liabilities that we have the ability to access at the measurement date;
|
• |
Level 2 – Valuations based on quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or for which all
significant inputs are observable, either directly or indirectly; and
|
• |
Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
Price Range
|
||||||||||||||||||||||||
Class and Period
|
Net Asset Value(1)
|
High
|
Low
|
High Sales Price
Premium
(Discount) to Net
Asset Value(2)
|
Low Sales Price
Premium
(Discount) to Net
Asset Value(2)
|
Cash Dividend Per Share(3)
|
||||||||||||||||||
Year Ended December 31, 2024
|
||||||||||||||||||||||||
Fourth Quarter (Through November 5, 2024)
|
*
|
$
|
13.24
|
$
|
10.73
|
*
|
*
|
*
|
||||||||||||||||
Third Quarter
|
$
|
13.28
|
$
|
12.00
|
$
|
10.64
|
-9.6
|
%
|
-19.9
|
%
|
$
|
0.25
|
||||||||||||
Second Quarter
|
$
|
13.56
|
$
|
12.38
|
$
|
9.61
|
-8.7
|
%
|
-29.1
|
%
|
$
|
0.25
|
||||||||||||
First Quarter
|
$
|
13.60
|
$
|
10.28
|
$
|
7.65
|
-24.4
|
%
|
-43.8
|
%
|
$
|
0.25
|
||||||||||||
Year Ended December 31, 2023
|
||||||||||||||||||||||||
Fourth Quarter
|
$
|
13.77
|
$
|
9.81
|
$
|
8.32
|
-28.8
|
%
|
-39.6
|
%
|
$
|
0.70
|
(6)
|
|||||||||||
Third Quarter
|
$
|
14.06
|
$
|
10.37
|
$
|
7.65
|
-26.3
|
%
|
-45.6
|
%
|
$
|
0.63
|
(6)
|
|||||||||||
Second Quarter
|
$
|
14.49
|
$
|
9.19
|
$
|
7.82
|
-36.3
|
%
|
-45.8
|
%
|
-
|
|||||||||||||
First Quarter
|
$
|
14.29
|
$
|
9.98
|
$
|
8.25
|
-30.2
|
%
|
-42.3
|
%
|
-
|
|||||||||||||
Year Ended December 31, 2022(4)
|
||||||||||||||||||||||||
Fourth Quarter
|
$
|
13.91
|
$
|
10.55
|
$
|
9.57
|
-24.2
|
%
|
-31.2
|
%
|
-
|
|||||||||||||
Third Quarter
|
$
|
13.73
|
$
|
10.74
|
$
|
9.00
|
-21.8
|
%
|
-34.5
|
%
|
-
|
|||||||||||||
Second Quarter
|
$
|
13.64
|
$
|
13.50
|
$
|
7.80
|
-1.0
|
%
|
-42.8
|
%
|
-
|
|||||||||||||
First Quarter(5)
|
$
|
13.61
|
$
|
14.41
|
$
|
12.57
|
5.9
|
%
|
-7.6
|
%
|
-
|
(1) |
Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset
values shown are based on outstanding shares at the end of the relevant quarter.
|
(2) |
Calculated as the respective high or low closing sales price less net asset value, divided by net asset value (in each case, as of the end of the applicable quarter).
|
(3) |
Represents the dividend or distribution declared in the relevant quarter.
|
(4) |
On November 8, 2022, our Board of Directors approved a change to our fiscal year end from March 31 to December 31.
|
(5) |
Shares of our common stock began trading on the Nasdaq Global Market on February 4, 2022 under the trading symbol “SSIC.” On October 2, 2024, our ticker symbol changed to “LIEN.”
|
(6) |
Consists of a quarterly dividend and a special dividend.
|
* |
Not determined at time of filing.
|
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Per Share
Amount |
Dividends Paid
|
|||||||||
August 10, 2023
|
Quarterly
|
September 15, 2023
|
September 29, 2023
|
$
|
0.23
|
$
|
1,429,375
|
|||||||
August 10, 2023
|
Special
|
September 15, 2023
|
September 29, 2023
|
$
|
0.40
|
$
|
2,485,869
|
|||||||
November 9, 2023
|
Quarterly
|
December 20, 2023
|
December 29, 2023
|
$
|
0.25
|
$
|
1,553,676
|
|||||||
November 9, 2023
|
Special
|
December 20, 2023
|
December 29, 2023
|
$
|
0.45
|
$
|
2,796,617
|
|||||||
March 8, 2024
|
Quarterly
|
March 20, 2024
|
March 28, 2024
|
$
|
0.25
|
$
|
1,553,736
|
|||||||
May 9, 2024
|
Quarterly
|
June 20, 2024
|
June 28, 2024
|
$
|
0.25
|
$
|
1,553,738
|
|||||||
August 8, 2024
|
Quarterly
|
September 19, 2024
|
September 27, 2024
|
$
|
0.25
|
$
|
1,553,741
|
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Shares
|
||||||
March 8, 2024
|
Quarterly
|
March 20, 2024
|
March 28, 2024
|
8
|
||||||
May 9, 2024
|
Quarterly
|
June 20, 2024
|
June 28, 2024
|
15
|
||||||
August 8, 2024
|
Quarterly
|
September 19, 2024
|
September 27, 2024
|
31
|
Declaration Date
|
Type
|
Record Date
|
Payment Date
|
Shares
|
||||||
August 10, 2023
|
Quarterly
|
September 15, 2023
|
September 29, 2023
|
12
|
||||||
August 10, 2023
|
Special
|
September 15, 2023
|
September 29, 2023
|
21
|
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
Change in Interest Rates
|
Interest Income
|
Interest expense
|
Net Income/(Loss)
|
|||||||||
Up 300 basis points
|
$
|
1,264
|
$
|
-
|
$
|
1,264
|
||||||
Up 200 basis points
|
843
|
-
|
843
|
|||||||||
Up 100 basis points
|
421
|
-
|
421
|
|||||||||
Down 100 basis points
|
(400
|
)
|
-
|
(400
|
)
|
|||||||
Down 200 basis points
|
(734
|
)
|
-
|
(734
|
)
|
|||||||
Down 300 basis points
|
(934
|
)
|
-
|
(934
|
)
|
Change in Interest Rates
|
Interest Income
|
Interest expense
|
Net Income/(Loss)
|
|||||||||
Up 300 basis points
|
$
|
1,390
|
$
|
-
|
$
|
1,390
|
||||||
Up 200 basis points
|
926
|
-
|
926
|
|||||||||
Up 100 basis points
|
463
|
-
|
463
|
|||||||||
Down 100 basis points
|
(463
|
)
|
-
|
(463
|
)
|
|||||||
Down 200 basis points
|
(883
|
)
|
-
|
(883
|
)
|
|||||||
Down 300 basis points
|
(1,146
|
)
|
-
|
(1,146
|
)
|
Item 4. |
Controls and Procedures
|
Item 1. |
Legal Proceedings
|
Item 1A. |
Risk Factors
|
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
Item 3. |
Defaults Upon Senior Securities
|
Item 4. |
Mine Safety Disclosures
|
Item 5. |
Other Information
|
Item 6. |
Exhibits
|
Exhibit
Number
|
Description of Exhibit
|
|
Purchase Agreement by and between the Company and Chicago Atlantic Loan Portfolio, LLC dated as of February 18, 2024(1)
|
||
Articles of Amendment and Restatement of the Company(2)
|
||
3.2 |
Articles of Amendment of the Company*
|
|
Amended and Restated Bylaws of the Company(2) | ||
10.1 |
Investment Advisory Agreement, dated October 1, 2024, between the Company and the Adviser(3)
|
|
License Agreement, dated October 1, 2024, between the Company and the Adviser(4)
|
||
Expense Limitation Agreement, dated October 1, 2024, between the Company and the
Adviser(5)
|
||
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
2002*
|
||
Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
2002*
|
||
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
|
||
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
|
* |
Filed herewith.
|
(1) |
Incorporated by reference to Exhibit 2.1 of the Company’s current report on Form 8-K filed on February 23, 2024.
|
(2) |
Incorporated by reference to the Company’s annual report on Form 10-K/A, filed on June 30, 2022.
|
(3) |
Incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed on October 7, 2024.
|
(4) |
Incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed on October 7, 2024.
|
(5) |
Incorporated by reference to Exhibit 10.3 of the Company’s current report on Form 8-K filed on October 7, 2024.
|
CHICAGO ATLANTIC BDC, INC.
|
||
By:
|
/s/ Andreas Bodmeier
|
|
Andreas Bodmeier
|
||
Chief Executive Officer (Principal Executive Officer)
|
||
By:
|
/s/ Umesh Mahajan
|
|
Umesh Mahajan
|
||
Chief Financial Officer (Principal Financial and Accounting Officer)
|
Silver Spike Investment Corp.
|
|||||
/s/ Umesh Mahajan
|
By:
|
/s/ Scott Gordon
|
|||
Name: Umesh Mahajan
|
Name: Scott Gordon
|
||||
Title: Secretary
|
Title: Chief Executive Officer
|
Date: November 7, 2024
|
By:
|
/s/ Andreas Bodmeier
|
Andreas Bodmeier
|
||
Chief Executive Officer
(Principal Executive Officer)
|
Date: November 7, 2024
|
By:
|
/s/ Umesh Mahajan
|
Umesh Mahajan
|
||
Chief Financial Officer
(Principal Financial Officer)
|
Date: November 7, 2024
|
By:
|
/s/ Andreas Bodmeier
|
Andreas Bodmeier
|
||
Chief Executive Officer
(Principal Executive Officer)
|
Date: November 7, 2024
|
By:
|
/s/ Umesh Mahajan
|
Umesh Mahajan
|
||
Chief Financial Officer
(Principal Financial Officer)
|